Literature DB >> 19342895

p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis.

Laura Senovilla1, Ilio Vitale, Lorenzo Galluzzi, Sonia Vivet, Nicholas Joza, Amena Ben Younes, Santiago Rello-Varona, Maria Castedo, Guido Kroemer.   

Abstract

Tetraploidy may constitute a metastable state leading to numeric and structural chromosome abnormalities that are associated with cancer. Here, we show that cultured primary p53(-/-) (but not wild type, WT) mouse mammary epithelial cells (MMECs) accumulate a tetraploid sub-population in vitro. This occurs spontaneously, yet can be exacerbated by the addition of microtubule inhibitors as well as of inhibitors of cytokinesis. As compared to WT cells, tetraploid p53(-/-) MMECs contain supernumerary centrosomes and exhibit a reduced propensity to initiate the mitochondrial pathway of apoptosis. Moreover, tetraploid p53(-/-) MMECs are more resistant against anthracyclin-induced cell killing than their diploid counterparts. Altogether, these data indicate that p53 normally suppresses the generation of tetraploid cells, presumably by activating the intrinsic pathway of apoptosis. In the absence of p53, tetraploid cells accumulate as a result of inhibited apoptosis, which contributes to the acquisition of chemotherapy resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342895     DOI: 10.4161/cc.8.9.8305

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  20 in total

1.  FLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperones.

Authors:  Tai-Long Pan; Shu-Yuan Hsu; Pei-Wen Wang; Ya-Ting Cheng; Yu-Chen Chang; Sudipta Saha; Jiwei Hu; Pin Ouyang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

3.  Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.

Authors:  Ilio Vitale; Laura Senovilla; Mohamed Jemaà; Mickaël Michaud; Lorenzo Galluzzi; Oliver Kepp; Lisa Nanty; Alfredo Criollo; Santiago Rello-Varona; Gwenola Manic; Didier Métivier; Sonia Vivet; Nicolas Tajeddine; Nicholas Joza; Alexander Valent; Maria Castedo; Guido Kroemer
Journal:  EMBO J       Date:  2010-02-25       Impact factor: 11.598

4.  Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.

Authors:  Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Alba Granados-Jaén; Bradley Downs; Yeong C Kim; San Ming Wang; Manuel Reina; Enric Espel
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  p53: guardian of ploidy.

Authors:  Yael Aylon; Moshe Oren
Journal:  Mol Oncol       Date:  2011-07-30       Impact factor: 6.603

6.  Immunosurveillance against tetraploidization-induced colon tumorigenesis.

Authors:  Alice Boilève; Laura Senovilla; Ilio Vitale; Delphine Lissa; Isabelle Martins; Didier Métivier; Stieneke van den Brink; Hans Clevers; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

7.  p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells.

Authors:  Takayuki Ikezoe; Jing Yang; Chie Nishioka; Akihito Yokoyama
Journal:  Int J Hematol       Date:  2009-12-16       Impact factor: 2.490

8.  Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention.

Authors:  Delphine Lissa; Laura Senovilla; Santiago Rello-Varona; Ilio Vitale; Mickaël Michaud; Federico Pietrocola; Alice Boilève; Florine Obrist; Chloé Bordenave; Pauline Garcia; Judith Michels; Mohamed Jemaà; Oliver Kepp; Maria Castedo; Guido Kroemer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

9.  A role for p38 in transcriptional elongation of p21 (CIP1) in response to Aurora B inhibition.

Authors:  Geeta Kumari; Tanja Ulrich; Stefan Gaubatz
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

10.  Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer.

Authors:  Alka Choudhary; Brittany Zachek; Robert F Lera; Lauren M Zasadil; Amber Lasek; Ryan A Denu; Hyunjung Kim; Craig Kanugh; Jennifer J Laffin; Josephine M Harter; Kari B Wisinski; Sandeep Saha; Beth A Weaver; Mark E Burkard
Journal:  Mol Cancer Ther       Date:  2015-11-19       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.